Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4916)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 24, 2020 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Galarza Fortuna GM, Dvir K. Circulating tumor DNA: Where are we now? A mini review of the literature. World J Clin Oncol 2020; 11(9): 723-731 [PMID: 33033694 DOI: 10.5306/wjco.v11.i9.723] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v11/i9/723.htm |
| Number | Citing Articles |
| 1 |
Joanna Kapeleris, Majid Ebrahimi Warkiani, Arutha Kulasinghe, Ian Vela, Liz Kenny, Rahul Ladwa, Kenneth O’Byrne, Chamindie Punyadeera. Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.859152
|
| 2 |
Dongju Won, Jinho Heo, Hongkyung Kim, Saeam Shin, Seung-Tae Lee. Clinical Application of Circulating Tumor DNA Analysis. Laboratory Medicine Online 2022; 12(4): 235 doi: 10.47429/lmo.2022.12.4.235
|
| 3 |
Enrico Mini, Ida Landini, Antonello Di Paolo, Gloria Ravegnini, Simona Saponara, Maria Frosini, Andrea Lapucci, Stefania Nobili. Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy. 2022; : 199 doi: 10.1016/B978-0-323-90190-1.00002-0
|
| 4 |
Ângela Carvalho, Gabriela Ferreira, Duarte Seixas, Catarina Guimarães-Teixeira, Rui Henrique, Fernando J. Monteiro, Carmen Jerónimo. Emerging Lab-on-a-Chip Approaches for Liquid Biopsy in Lung Cancer: Status in CTCs and ctDNA Research and Clinical Validation. Cancers 2021; 13(9): 2101 doi: 10.3390/cancers13092101
|
| 5 |
Matthew Krell, Brent Llera, Zachary J. Brown. Circulating Tumor DNA and Management of Colorectal Cancer. Cancers 2023; 16(1): 21 doi: 10.3390/cancers16010021
|
| 6 |
Virginia Liberini, Martin W. Huellner, Serena Grimaldi, Monica Finessi, Philippe Thuillier, Alfredo Muni, Riccardo E. Pellerito, Mauro G. Papotti, Alessandro Piovesan, Emanuela Arvat, Désirée Deandreis. The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future. Diagnostics 2020; 10(12): 1083 doi: 10.3390/diagnostics10121083
|
| 7 |
Patrick Kirchweger, Helwig Valentin Wundsam, Holger Rumpold. Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies. World Journal of Clinical Oncology 2022; 13(6): 473-484 doi: 10.5306/wjco.v13.i6.473
|
| 8 |
Olga Karpov, Meir Lahav, Ofir Wolach, Pia Raanani, Dan Peer, Tal Kaplan, Orit Uziel. Identification of Cancer Cells in the Human Body by Anti-Telomerase Peptide Antibody: Towards the Isolation of Circulating Tumor Cells. International Journal of Molecular Sciences 2022; 23(21): 12872 doi: 10.3390/ijms232112872
|
| 9 |
Vahid Yaghoubi Naei, Pritam Bordhan, Fatemeh Mirakhorli, Motahare Khorrami, Jesus Shrestha, Hojjatollah Nazari, Arutha Kulasinghe, Majid Ebrahimi Warkiani. Advances in novel strategies for isolation, characterization, and analysis of CTCs and ctDNA. Therapeutic Advances in Medical Oncology 2023; 15 doi: 10.1177/17588359231192401
|